Literature DB >> 16646746

Modifiable risk factors for age-related macular degeneration.

Robyn H Guymer1, Elaine Wei-Tinn Chong.   

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in Australia and other Western countries. As there is no cure for AMD, and treatments to stop its progression have met with limited success, there is an interest in identifying modifiable risk factors to prevent or slow disease progression. To date, smoking is the only proven modifiable risk factor for AMD. Other factors under study include (i) cardiovascular risk factors such as hypertension, body mass index, and atherosclerosis; and (ii) dietary risk factors including fat and antioxidant intake, but so far these studies have produced conflicting results. Dietary fat in relation to AMD has recently attracted media attention. Despite very limited work supporting an association between vegetable fat and AMD, widespread publicity advocating margarine as a cause of AMD and encouraging use of butter instead has caused confusion and anxiety among sufferers of AMD and the general public, as well as concern among health professionals. The antioxidant carotenoids--lutein and zeaxanthin--found in dark green or yellow vegetables exist in high concentrations in the macula and are hypothesised to play a protective role. Of nine controlled trials of supplementation with carotenoids and other antioxidants, three suggested that various combinations of antioxidants and carotenoids were protective. While a low-fat diet rich in dark green and yellow vegetables is advocated in general, any specific recommendations regarding certain fats or antioxidant supplementation and AMD are not based on consistent findings at this stage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16646746

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  20 in total

Review 1.  [Vitamins for the eyes? Risks and opportunities for physician and patient].

Authors:  R Grossklaus; K J Henning
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

2.  Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study.

Authors:  Amir L Butt; Elisa T Lee; Ronald Klein; Dana Russell; Gerald Ogola; Ann Warn; Ronald M Kingsley; Jeunliang Yeh
Journal:  Ophthalmology       Date:  2011-02-18       Impact factor: 12.079

3.  The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).

Authors:  Peter James Francis
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

4.  Understanding the patient's lived experience of neovascular age-related macular degeneration: a qualitative study.

Authors:  C McCloud; S Lake
Journal:  Eye (Lond)       Date:  2015-09-18       Impact factor: 3.775

5.  Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up.

Authors:  Paul T Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

6.  Correlation between the interactions of ABCA4 polymorphisms and smoking with the susceptibility to age-related macular degeneration.

Authors:  Ying Wu; Lei Tian; Yifei Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

7.  Zeaxanthin is bioavailable from genetically modified zeaxanthin-rich potatoes.

Authors:  Achim Bub; Jutta Möseneder; Gerhard Wenzel; Gerhard Rechkemmer; Karlis Briviba
Journal:  Eur J Nutr       Date:  2008-03-04       Impact factor: 5.614

8.  Overall diet quality and age-related macular degeneration.

Authors:  Martha P Montgomery; Freya Kamel; Margaret A Pericak-Vance; Jonathan L Haines; Eric A Postel; Anita Agarwal; Marie Richards; William K Scott; Silke Schmidt
Journal:  Ophthalmic Epidemiol       Date:  2010 Jan-Feb       Impact factor: 1.648

9.  Hyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cells.

Authors:  Xia Li; Yan Cai; Yu-Sheng Wang; Yuan-Yuan Shi; Wei Hou; Chun-Sheng Xu; Hai-Yan Wang; Zi Ye; Li-Bo Yao; Jian Zhang
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  Effect of lutein and antioxidant supplementation on VEGF expression, MMP-2 activity, and ultrastructural alterations in apolipoprotein E-deficient mouse.

Authors:  Patricia Fernández-Robredo; Luis M Sádaba; Angel Salinas-Alamán; Sergio Recalde; José A Rodríguez; Alfredo García-Layana
Journal:  Oxid Med Cell Longev       Date:  2013-04-30       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.